Refining Timely Diagnosis of Early Syphilis by Using Treponema pallidum PCR or IgM Immunoblotting Next to Conventional Serology for Syphilis.
Jacky FlipseAnne-Marie NiekampAnne DirksNicole H T M Dukers-MuijrersChristian J P A HoebePetra F G WolffsInge H M van LooPublished in: Journal of clinical microbiology (2023)
Treponema pallidum subsp. pallidum is a fastidious spirochete and the etiologic agent of syphilis, a sexually transmitted infection (STI). Syphilis diagnoses and disease staging are based on clinical findings and serologic testing. Moreover, according to most international guidelines, PCR analysis of swab samples from genital ulcers is included in the screening algorithm where possible. It has been suggested that PCR might be omitted from the screening algorithm due to low added value. As an alternative to PCR, IgM serology might be used. In this study, we wanted to establish the added value of PCR and IgM serology for diagnosing primary syphilis. Added value was defined as finding more cases of syphilis, preventing overtreatment, or limiting the extent of partner notification to more recent partners. We found that both PCR and IgM immunoblotting could aid the timely diagnosis of early syphilis in ~24% to 27% of patients. PCR has the greatest sensitivity and can be applied to cases with an ulcer with suspected reinfection or primary infection. In the absence of lesions, the IgM immunoblot could be used. However, the IgM immunoblot has better performance in cases with suspected primary infection than in reinfections. The target population, testing algorithm, time pressures, and costs should determine whether either test provides sufficient value to be implemented in clinical practice.
Keyphrases
- men who have sex with men
- human immunodeficiency virus
- hiv testing
- real time pcr
- machine learning
- clinical practice
- deep learning
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- hepatitis c virus
- pulmonary embolism
- lymph node
- hiv infected
- antiretroviral therapy
- sars cov
- prognostic factors
- patient reported outcomes